Interestingly, IRS-4 is overexpressed in both benign proliferative lesions, such as uterine leiomyomas [19] and subungual exostosis [20], and malignant diseases, such as breast cancer [21], leukemia [22], lung cancer [23], colorectal cancer [24,25], and liver cancer [26]. Here, IRS4 is linked to liver cancer.